Post by ck4829 on Apr 17, 2018 14:00:35 GMT
Congressman Pushed Bills That Would've Helped Drug Company He Owns
Rep. Chris Collins sponsored legislation beneficial to the pharmaceutical industry, and especially the company where he’s a director. Why won’t the House investigate?
Rep. Chris Collins (R-NY) has sponsored several bills that would have benefited a drug company in which he is the lead shareholder, a Daily Beast investigation has found.
Collins is also trying to make changes to a government program that would save the company millions of dollars if its drug is approved by the FDA.
Collins’s office says he doesn’t believe his bills represent a conflict of interest, but he is already accused by independent Office of Congressional Ethics of violating House ethics rules and U.S. securities law for his dealings with the drug company.
The Daily Beast found at least four bills that Collins drafted or sponsored that would have directly affected the drug company, Innate Immunotherapeutics:
A 2013 bill that would have appropriated more money to an NIH grant program from which Innate previously received $300,000.
more
www.thedailybeast.com/congressman-pushed-bills-that-helped-his-drug-company?ref=home
Rep. Chris Collins sponsored legislation beneficial to the pharmaceutical industry, and especially the company where he’s a director. Why won’t the House investigate?
Rep. Chris Collins (R-NY) has sponsored several bills that would have benefited a drug company in which he is the lead shareholder, a Daily Beast investigation has found.
Collins is also trying to make changes to a government program that would save the company millions of dollars if its drug is approved by the FDA.
Collins’s office says he doesn’t believe his bills represent a conflict of interest, but he is already accused by independent Office of Congressional Ethics of violating House ethics rules and U.S. securities law for his dealings with the drug company.
The Daily Beast found at least four bills that Collins drafted or sponsored that would have directly affected the drug company, Innate Immunotherapeutics:
A 2013 bill that would have appropriated more money to an NIH grant program from which Innate previously received $300,000.
more
www.thedailybeast.com/congressman-pushed-bills-that-helped-his-drug-company?ref=home